Entrepreneurs

The Madison-based radiopharmaceutical firm Cellectar has raised $13 million in a private offering led by Venture Investors. The funds will be used for a Phase 1 clinical trial that could validate the company's lead oncology candidate, a cancer-fighting molecule that has shown promise in preclinical...

Gov. Jim Doyle's new plans to stimulate angel and venture investment and manufacturing innovation received high marks from members of the Wisconsin Technology Council Board. The board, comprised of business leaders and state officials, voted Tuesday to endorse the plan in concept. ...

The Wisconsin Alumni Research Foundation, the licensing arm of the University of Wisconsin-Madison, has announced a licensing agreement with the California firm BioTime. The agreement involves patents and patent applications related to human embryonic stem cell technology created by professor James Thomson. ...

Business plans are a critical tool in the proper planning and launch of new ventures, and they will be the focal point of the Northeast Wisconsin Business Plan Competition. However, time is running out as entries for the contest are due by 5 p.m. on...

Like many other aspects of personal finance, the decision to sell your business will depend largely on tax implications. As columnist and attorney Joe Boucher explains in this edition of Early Stage, business owners face a choice between selling their ownership interests or selling their...

Technically skilled people can be lone wolves and tend to have no appetite for managing people, let alone setting business strategy as part of upper management. How, then, do the chief information officers that manage them keep them motivated when they advance to that point...

Two Madison companies have beefed up their management teams with key appointments. Third Wave Technologies has appointed Christopher Burton as senior vice president of sales and marketing, and Parts Now has a new CEO - Bruce Hagen, who held the same position with Conney Safety...

Affymetrix executive Chris Kendrick-Parker will help direct the future of GenTel Biosciences after his appointment to the company's Board of Directors. Kendrick-Parker brings more than 20 years of experience in the life science industry to the GenTel Board, including management of sales and marketing for...